Open access
76
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France
Maud Pignata1 HEVA-HEOR, LyonCorrespondence[email protected]
, Christos Chouaid2 Centre Hospitalier, Intercommunal de Créteil, Créteil
, Katell Le Lay3 Boehringer Ingelheim, Paris, France
, Laura Luciani3 Boehringer Ingelheim, Paris, France
, Ceilidh McConnachie4 Ossian Health Economics and Communications, Basel, Switzerland
, James Gordon5 Boehringer Ingelheim, GmbH, Germany
& Stéphane Roze1 HEVA-HEOR, Lyon
show all
Pages 655-668
|
Published online: 25 Oct 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.